top banner imagetop banner mobile image

Press Releases

Date Title
11/13/20
TherapeuticsMD Announces Closing of its Underwritten Public Offering of Common Stock
11/13/20
TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference
11/10/20
TherapeuticsMD Announces Pricing of $30 Million Public Offering of Common Stock
11/09/20
TherapeuticsMD Announces Underwritten Public Offering of its Common Stock
11/09/20
TherapeuticsMD® Announces Third Quarter 2020 Financial Results
10/29/20
TherapeuticsMD to Report Third Quarter 2020 Results on November 9, 2020
10/26/20
POPSUGAR Launches New Women’s Health Destination, “Full Disclosure,” in Collaboration With TherapeuticsMD
10/09/20
TherapeuticsMD Supports the Importance of Empowering Women to Make Informed Choices about their Sexual and Reproductive Health
09/25/20
TherapeuticsMD Provides Update on Third Quarter Progress
09/21/20
Knight and TherapeuticsMD Announce Health Canada Approval of BIJUVA®
09/10/20
TherapeuticsMD Announces Participation at Two Upcoming Virtual Investor Conferences
09/09/20
TherapeuticsMD Announces Patent Updates for ANNOVERA®
08/25/20
Knight and TherapeuticsMD Announce Health Canada Approval of IMVEXXY®
08/06/20
TherapeuticsMD® Announces Second Quarter 2020 Financial Results
07/29/20
TherapeuticsMD to Report Second Quarter 2020 Results on August 6, 2020
07/15/20
TherapeuticsMD and Nurx Expand Access to ANNOVERA®
06/01/20
TherapeuticsMD Announces Appointment of James C. D’Arecca as Chief Financial Officer and Retirement of Daniel A. Cartwright as Chief Financial Officer
05/08/20
TherapeuticsMD Announces Participation at the BofA Securities 2020 Health Care Conference
05/06/20
TherapeuticsMD Announces First Quarter 2020 Financial Results
04/29/20
TherapeuticsMD Announces Issuance of First Orange Book Listable U.S. Patent for ANNOVERA®
04/28/20
TherapeuticsMD to Report First Quarter 2020 Results on May 6, 2020
04/22/20
TherapeuticsMD Further Strengthens Board with Appointment of New Independent Director
03/26/20
TherapeuticsMD Provides COVID-19-Related Business Update
03/24/20
TherapeuticsMD Strengthens Board with Appointment of Industry Leaders
03/16/20
TherapeuticsMD Provides Business Update on COVID-19 Pandemic
02/27/20
TherapeuticsMD Announces Participation at the Cowen 40th Annual Healthcare Conference
02/20/20
TherapeuticsMD Announces Fourth Quarter and Full-Year 2019 Financial Results
02/13/20
TherapeuticsMD and Afaxys Enter Into Agreement to Expand Access to ANNOVERA® in the U.S. Public Health Sector
02/10/20
TherapeuticsMD to Report Fourth Quarter 2019 Results on February 20, 2020
02/03/20
TherapeuticsMD Announces Submission of New Drug Application Prior Approval Efficacy Supplement to the U.S. Food and Drug Administration for Lower Dose of BIJUVA®
01/07/20
TherapeuticsMD, an Innovative Women’s Healthcare Company, and PlushCare, a Virtual Health Platform, Announce Enhanced Access to Women’s Health Products
01/06/20
TherapeuticsMD Announces Participation at the JP Morgan Healthcare Conference